MD1788F2 - Derivati de 9-O-oxima a Eritromicinei A, compozitie farmaceutica pe baza lor si metoda de tratament al bolilor infectioase - Google Patents

Derivati de 9-O-oxima a Eritromicinei A, compozitie farmaceutica pe baza lor si metoda de tratament al bolilor infectioase

Info

Publication number
MD1788F2
MD1788F2 MD97-0243A MD970243A MD1788F2 MD 1788 F2 MD1788 F2 MD 1788F2 MD 970243 A MD970243 A MD 970243A MD 1788 F2 MD1788 F2 MD 1788F2
Authority
MD
Moldova
Prior art keywords
erythromycin
treatment
pharmaceutical composition
infectious diseases
base
Prior art date
Application number
MD97-0243A
Other languages
English (en)
Other versions
MD970243A (ro
MD1788G2 (ro
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of MD970243A publication Critical patent/MD970243A/ro
Publication of MD1788F2 publication Critical patent/MD1788F2/ro
Publication of MD1788G2 publication Critical patent/MD1788G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MD97-0243A 1994-12-13 1995-12-07 Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase MD1788G2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (3)

Publication Number Publication Date
MD970243A MD970243A (ro) 1999-05-31
MD1788F2 true MD1788F2 (ro) 2001-11-30
MD1788G2 MD1788G2 (ro) 2002-05-31

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0243A MD1788G2 (ro) 1994-12-13 1995-12-07 Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase

Country Status (35)

Country Link
US (1) US5847092A (ro)
EP (1) EP0797579B1 (ro)
JP (1) JPH10510520A (ro)
KR (1) KR100367559B1 (ro)
CN (1) CN1046535C (ro)
AP (1) AP739A (ro)
AT (1) ATE190620T1 (ro)
AU (1) AU690791B2 (ro)
BG (1) BG63261B1 (ro)
BR (1) BR9510015A (ro)
CA (1) CA2207029A1 (ro)
CZ (1) CZ289943B6 (ro)
DE (1) DE69515694T2 (ro)
DK (1) DK0797579T3 (ro)
EE (1) EE03401B1 (ro)
ES (1) ES2144154T3 (ro)
FI (1) FI972493A0 (ro)
GE (1) GEP20012391B (ro)
GR (1) GR3033622T3 (ro)
HU (1) HU220631B1 (ro)
IT (1) IT1276901B1 (ro)
LT (1) LT4276B (ro)
LV (1) LV11898B (ro)
MD (1) MD1788G2 (ro)
NO (1) NO309816B1 (ro)
NZ (1) NZ297446A (ro)
OA (1) OA10491A (ro)
PL (1) PL182053B1 (ro)
PT (1) PT797579E (ro)
RO (1) RO116282B1 (ro)
RU (1) RU2152951C1 (ro)
SI (1) SI9520124A (ro)
TJ (1) TJ306B (ro)
UA (1) UA48958C2 (ro)
WO (1) WO1996018633A1 (ro)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
RU2186389C1 (ru) * 2001-01-09 2002-07-27 Государственное федеральное учреждение науки Уральский научно-исследовательский институт травматологии и ортопедии Способ культивирования h. influenzae из носоглоточной слизи (варианты)
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
RU2207120C1 (ru) * 2001-12-29 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство брилид антибиотического действия
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
RU2240112C1 (ru) * 2003-06-09 2004-11-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
KR880009960A (ko) 1987-02-24 1988-10-06 데이빗 로버츠 화학적 화합물
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives

Also Published As

Publication number Publication date
FI972493L (fi) 1997-06-12
ES2144154T3 (es) 2000-06-01
RO116282B1 (ro) 2000-12-29
MD970243A (ro) 1999-05-31
AU690791B2 (en) 1998-04-30
IT1276901B1 (it) 1997-11-03
HUT77126A (hu) 1998-03-02
JPH10510520A (ja) 1998-10-13
DE69515694D1 (de) 2000-04-20
ITMI942496A0 (it) 1994-12-13
RU2152951C1 (ru) 2000-07-20
SI9520124A (sl) 1998-04-30
TJ306B (en) 2001-08-06
UA48958C2 (uk) 2002-09-16
BR9510015A (pt) 1997-10-28
US5847092A (en) 1998-12-08
CZ289943B6 (cs) 2002-04-17
LV11898B (en) 1998-03-20
AP739A (en) 1999-03-24
AU4260396A (en) 1996-07-03
KR100367559B1 (ko) 2003-04-21
PL320688A1 (en) 1997-10-27
PL182053B1 (pl) 2001-10-31
NZ297446A (en) 1999-06-29
AP9700989A0 (en) 1997-07-31
MD1788G2 (ro) 2002-05-31
NO309816B1 (no) 2001-04-02
MX9704253A (es) 1997-09-30
PT797579E (pt) 2000-08-31
OA10491A (en) 2002-04-10
NO972702D0 (no) 1997-06-12
CN1046535C (zh) 1999-11-17
BG101570A (bg) 1998-02-27
EP0797579B1 (en) 2000-03-15
LV11898A (lv) 1997-12-20
EP0797579A1 (en) 1997-10-01
GR3033622T3 (en) 2000-10-31
NO972702L (no) 1997-08-13
ATE190620T1 (de) 2000-04-15
DK0797579T3 (da) 2000-06-05
CA2207029A1 (en) 1996-06-20
CZ178697A3 (en) 1997-12-17
ITMI942496A1 (it) 1996-06-13
FI972493A7 (fi) 1997-06-12
FI972493A0 (fi) 1997-06-12
LT4276B (lt) 1998-01-26
EE03401B1 (et) 2001-04-16
EE9700124A (et) 1997-12-15
LT97116A (en) 1997-10-27
DE69515694T2 (de) 2000-10-26
GEP20012391B (en) 2001-03-25
HU220631B1 (hu) 2002-03-28
CN1169727A (zh) 1998-01-07
BG63261B1 (bg) 2001-07-31
WO1996018633A1 (en) 1996-06-20

Similar Documents

Publication Publication Date Title
MD1233B1 (ro) Derivati de eritromicina, procedeu de preparare a lor si compozitie farmaceu-tica pe baza acestora
CA2387356A1 (en) Crystal form 0 and form i of clarithromycin and uses thereof
CA2145826A1 (en) Lipopeptide derivatives, a process for their preparation and their use
IE832652L (en) Derivatives of epimeric azahomoerythromycin.
MD1788F2 (ro) Derivati de 9-O-oxima a Eritromicinei A, compozitie farmaceutica pe baza lor si metoda de tratament al bolilor infectioase
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG103947A (en) Derivatives of 9-oxymerythromycin
AU1747201A (en) Compounds with antibacterial and antiparasitic properties
BG105543A (en) Novel macrolide antibiotics
CA2219656A1 (en) Antibacterial cephalosporins
IL123551A0 (en) Tricyclic erythromycin derivatives
CA2138289A1 (en) N-substituted azabicycloheptane derivatives, the preparation and use thereof
CA2339174A1 (en) Aminosterol compounds and uses thereof
EP0136830A3 (en) Azahomoerythromycin d derivative and intermediates therefor
MX9708611A (es) Compuestos de dialquiltiacumicina.
AU7498494A (en) New bis-naphthalimides for the treatment of cancer
AU2998797A (en) 6-o-substituted erythromycin compounds and method for making same
CA2176144A1 (en) Anthracycline derivatives for treatment of amyloidosis
AU8889991A (en) Fluorine compounds
MY133397A (en) Novel crystalline forms of a macrolide antibiotic
AU5390900A (en) Potassium channel blocking agents
AU644474B2 (en) Heteroarylmethylbenzenes
AU7649391A (en) 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation
PL324884A1 (en) Application of prostane derivatives and their compositions with antibiotics in treating bacterial infections
GR3031709T3 (en) Octahydro-2-naphthalenecarboxylic acid derivative, its production and use.

Legal Events

Date Code Title Description
PD99 Pending application
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees